Neurotech International Limited announced the appointment of Mr. Peter Griffiths as Chief Executive Officer and Managing Director, effective immediately. Mr. Griffiths, who has been on Neurotech's Board since May 2016 and an investor in the company since 2015, has more than 20 years' experience in the technology sector, with success building and scaling software businesses. He has a particular focus on opportunities in advanced analytics, cloud transformation and big data.

Mr. Griffiths will lead a new chapter in the growth of Neurotech as it re-focuses its commercialisation strategy by leveraging the key building blocks of an innovative and unique home care product for autism therapy, the success of the US Clinical Trial and existing cloud infrastructure. In conjunction with the appointment of Peter Griffiths as CEO, Neurotech also announces the retirement of Wolfgang Storf from his position as CEO and Managing Director of the company. Peter has more than 20 years of leadership experience in the technology sector, in roles ranging from founder and start-up CEO to C-suite executive across significant portfolios at Cognos, IBM and CA Technologies.

Peter is currently an adviser to Bridge Growth Partners, New York, and serves on the board of Accedian, to drive the best possible user experience.